FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Luciana Irtelli

Research Profile

Concepts & Ideas

Procedures

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Cesare Gridelli; Giuseppe Grimaldi; Luciana Irtelli; Paolo Maione; Alessandro Morabito; Francovito Piantedosi; Giuseppe Airoma; Roberto Bianco; Giovanni De Chiara; Raffaele Costanzo; Bruno Daniele; Antonio Rossi; Ferdinando Riccardi
Treatment of pulmonary neuroendocrine tumours: State of the art and future developments.
Antonio Marchetti; Michele Milella; Lara Felicioni; Federico Cappuzzo; Luciana Irtelli; Maela Del Grammastro; Mariagrazia Sciarrotta; Sara Malatesta; Carmen Nuzzo; Giovanna Finocchiaro; Bruno Perrucci; Donatella Carlone; Alain J Gelibter; Anna Ceribelli; Andrea Mezzetti; Stefano Iacobelli; Francesco Cognetti; Fiamma Buttitta
Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clones.
Ida Iurisci; tyvin rich; Francis Lévi; Pasquale F Innominato; Nicola Tinari; Luciana Irtelli; Michele De Tursi; Antonino Grassadonia; Stefano Iacobelli
Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Luciana Irtelli (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Cesare Gridelli; Giuseppe Grimaldi; Luciana Irtelli; Paolo Maione; Alessandro Morabito; Francovito Piantedosi; Giuseppe Airoma; Roberto Bianco; Giovanni De Chiara; Raffaele Costanzo; Bruno Daniele; Antonio Rossi; Ferdinando Riccardi
Treatment of pulmonary neuroendocrine tumours: State of the art and future developments.
Cancer treatment reviews 2013;39(5):466-72.
2009: Antonio Marchetti; Michele Milella; Lara Felicioni; Federico Cappuzzo; Luciana Irtelli; Maela Del Grammastro; Mariagrazia Sciarrotta; Sara Malatesta; Carmen Nuzzo; Giovanna Finocchiaro; Bruno Perrucci; Donatella Carlone; Alain J Gelibter; Anna Ceribelli; Andrea Mezzetti; Stefano Iacobelli; Francesco Cognetti; Fiamma Buttitta
Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clones.
Neoplasia (New York, N.Y.) 2009;11(10):1084-92.
2007: Ida Iurisci; tyvin rich; Francis Lévi; Pasquale F Innominato; Nicola Tinari; Luciana Irtelli; Michele De Tursi; Antonino Grassadonia; Stefano Iacobelli
Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(16):e17-9.
2000: Clara Natoli; M T Scognamiglio; M T Martino; Luciana Irtelli; Michele De Tursi; Ettore Cianchetti; E Mascitelli; Nicola Tinari; Stefano Iacobelli
Chronomodulated infusion of cisplatin, 5-fluorouracil and folinic acid: lack of activity in advanced colorectal cancer.
Anticancer research 2000;20(2B):1253-6.
1998: Stefano Iacobelli; Luciana Irtelli; Rocco Sacco; M Martino; E Mascitelli; L Basilico; M Scognamiglio; Clara Natoli; O Fusco; Nicola Tinari; V Beltrami
A phase II study of neoadjuvant chemotherapy with cisplatin epirubicin and VP-16 for stage III unresectable non-small cell lung cancer.
Anticancer research 1998;18(3B):2081-4.
1997: Francesco Boccardo; Domenico Amoroso; Stefano Iacobelli; Luciana Irtelli; Antonio Farris; Giorgio Mustacchi; Mario Mesiti; Fulvio Brema; P Pacini; E Cortesi; P Nardini; G Guida; C Langenaeken
Clinical efficacy and endocrine activity of vorozole in postmenopausal breast cancer patients. Results of a multicentric phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(8):745-50.
1996: Clara Natoli; V Salini; Luciana Irtelli; M T Martino; C Garufi; A Grassadonia; Bruno Fiorentino; Stefano Iacobelli
A phase I study of 5-day continuous venous infusion of carboplatin at circadian rhythm-modulated rate compared with constant rate.
Anticancer research 1996;16(3A):1275-9.
1995: Clara Natoli; M T Martino; Luciana Irtelli; N D'Ostilio; L Basilico; Stefano Iacobelli
Chronomodulated infusion of 5-fluorouracil, folinic acid and carboplatin in colorectal cancer: a pilot study.
Anticancer research 1995;15(6B):2841-2.
1995: Stefano Iacobelli; C Garufi; Luciana Irtelli; M T Martino; F Santobuono; G Vicario; Nicola Tinari; Bruno Fiorentino; P Innocenti; Clara Natoli
A phase I study of recombinant interferon-alpha administered as a seven-day continuous venous infusion at circadian-rhythm modulated rate in patients with cancer.
American journal of clinical oncology 1995;18(1):27-31.
1992: Cesare Gridelli; Stefano Iacobelli; T Martino; Clara Natoli; Giovanni Ferrante; Mattia Gentile; Luciana Irtelli; V Beltrami; Antonio Rossi; Angelo Raffaele Bianco
Neoadjuvant chemotherapy with cisplatin, epirubicin and VP-16 for stage IIIA-IIIB non-small-cell lung cancer: a pilot study.
Tumori 1992;78(6):377-9.